Limits...
Clinical outcome after the use of a new craniocaudal expandable implant for vertebral compression fracture treatment: one year results from a prospective multicentric study.

Noriega D, Krüger A, Ardura F, Hansen-Algenstaedt N, Hassel F, Barreau X, Beyerlein J - Biomed Res Int (2015)

Bottom Line: Statistically significant improvements were found regarding pain, function, and quality of life.The global pain score reduction at 1 year was 80.9% compared to the preoperative situation and the result of the Oswestry Disability Index showed a decrease from 65.0% at baseline to 10.5% at 12 months postoperatively.No device- or surgery-related complications were found.

View Article: PubMed Central - PubMed

Affiliation: Spine-Unit, University Hospital Valladolid, 47008 Valladolid, Spain.

ABSTRACT
The purpose of this prospective multicentric observational study was to confirm the safety and clinical performance of a craniocaudal expandable implant used in combination with high viscosity PMMA bone cement for the treatment of vertebral compression fractures. Thirty-nine VCFs in 32 patients were treated using the SpineJack minimally invasive surgery protocol. Outcome was determined by using the Visual Analogue Scale for measuring pain, the Oswestry Disability Index for scoring functional capacity, and the self-reporting European Quality of Life scores for the quality of life. Safety was evaluated by reporting all adverse events. The occurrence of cement leakages was assessed by either radiographs or CT scan or both. Statistically significant improvements were found regarding pain, function, and quality of life. The global pain score reduction at 1 year was 80.9% compared to the preoperative situation and the result of the Oswestry Disability Index showed a decrease from 65.0% at baseline to 10.5% at 12 months postoperatively. The cement leakage rate was 30.8%. No device- or surgery-related complications were found. This observational study demonstrates promising and persistent results consisting of immediate and sustained pain relief and durable clinical improvement after the procedure and throughout the 1-year follow-up period.

Show MeSH

Related in: MedlinePlus

Pain score (VAS) at baseline, after procedure, and at 6-month and at 12-month follow-up.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4309217&req=5

fig6: Pain score (VAS) at baseline, after procedure, and at 6-month and at 12-month follow-up.

Mentions: There was statistically significant, immediate, and long lasting reduction in pain as result of the procedure. The overall improvement in pain (VAS), after treatment (48–72 hours), and at 6 and 12 months was statistically significant (P < 0.001). The results are illustrated in Figure 6. A reduction in pain of >1.5 on the VAS scale is considered a meaningful change for back pain, MIC (minimal important change) [20].


Clinical outcome after the use of a new craniocaudal expandable implant for vertebral compression fracture treatment: one year results from a prospective multicentric study.

Noriega D, Krüger A, Ardura F, Hansen-Algenstaedt N, Hassel F, Barreau X, Beyerlein J - Biomed Res Int (2015)

Pain score (VAS) at baseline, after procedure, and at 6-month and at 12-month follow-up.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4309217&req=5

fig6: Pain score (VAS) at baseline, after procedure, and at 6-month and at 12-month follow-up.
Mentions: There was statistically significant, immediate, and long lasting reduction in pain as result of the procedure. The overall improvement in pain (VAS), after treatment (48–72 hours), and at 6 and 12 months was statistically significant (P < 0.001). The results are illustrated in Figure 6. A reduction in pain of >1.5 on the VAS scale is considered a meaningful change for back pain, MIC (minimal important change) [20].

Bottom Line: Statistically significant improvements were found regarding pain, function, and quality of life.The global pain score reduction at 1 year was 80.9% compared to the preoperative situation and the result of the Oswestry Disability Index showed a decrease from 65.0% at baseline to 10.5% at 12 months postoperatively.No device- or surgery-related complications were found.

View Article: PubMed Central - PubMed

Affiliation: Spine-Unit, University Hospital Valladolid, 47008 Valladolid, Spain.

ABSTRACT
The purpose of this prospective multicentric observational study was to confirm the safety and clinical performance of a craniocaudal expandable implant used in combination with high viscosity PMMA bone cement for the treatment of vertebral compression fractures. Thirty-nine VCFs in 32 patients were treated using the SpineJack minimally invasive surgery protocol. Outcome was determined by using the Visual Analogue Scale for measuring pain, the Oswestry Disability Index for scoring functional capacity, and the self-reporting European Quality of Life scores for the quality of life. Safety was evaluated by reporting all adverse events. The occurrence of cement leakages was assessed by either radiographs or CT scan or both. Statistically significant improvements were found regarding pain, function, and quality of life. The global pain score reduction at 1 year was 80.9% compared to the preoperative situation and the result of the Oswestry Disability Index showed a decrease from 65.0% at baseline to 10.5% at 12 months postoperatively. The cement leakage rate was 30.8%. No device- or surgery-related complications were found. This observational study demonstrates promising and persistent results consisting of immediate and sustained pain relief and durable clinical improvement after the procedure and throughout the 1-year follow-up period.

Show MeSH
Related in: MedlinePlus